-
GLP-1 drugs could reduce US death rates by 3.5% over next 20 years, says RGA
11 November 2025Ozempic, Wegovy and Mounjaro are among the most common GLP -1 drugs currently available
-
UK's CMI proposes major mortality model overhaul
27 February 2025Insurers will need to adapt assumptions as life expectancy modelling shifts